Sanofi Showcases Long-Term Benefits Of Dupixent For Severe Asthma

Another Boost For Blockbuster

 
• By Kevin Grogan

While many analysts have been focusing on the growth potential of Regeneron-partnered Dupixent in atopic dermatitis, the French giant has been highlighting the biologic's benefits for asthma with three-year data presented at the ERS meeting.

inhaler
Dupixent reduced rates of severe asthma attacks in extension study • Source: Shutterstock

More from Respiratory

More from Therapy Areas